Loading clinical trials...
Loading clinical trials...
A Phase 1, Two-Part Study to Assess the Safety and Pharmacokinetics of Tablet and Capsule Formulations of HU6 in Obese Subjects.
Conditions
Interventions
HU6 Tablet
HU6 Capsule
Locations
1
United States
Nucleus Network
Minneapolis, Minnesota, United States
Start Date
September 15, 2022
Primary Completion Date
January 30, 2023
Completion Date
March 15, 2023
Last Updated
March 20, 2023
NCT07310901
NCT07163455
NCT03821636
NCT06599918
NCT07020741
NCT04893954
Lead Sponsor
Rivus Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions